Sellas Life Sciences Group, a biopharmaceutical company focused on developing innovative immunotherapeutic products to treat a variety of cancers, announced on 15 November 2016 that it had moved its head office from Switzerland to Bermuda.
Ross Webber, CEO of the Bermuda Business Development Agency, has commented as follows:
“We have been working for a while to attract biotech and life-science companies to Bermuda, and the move here by Sellas is a very positive development that not only creates jobs but also helps diversify our economy.
“The BDA has worked with Sellas and its advisers for nearly six months, and we are proud to see them establish a physical presence on the island. It brings new jobs for Bermudians immediately, and we fully expect more will follow.”
For more information, see: